Premium
Metabotropic glutamate receptor 5 (mGlu 5 )‐positive allosteric modulators differentially induce or potentiate desensitization of mGlu 5 signaling in recombinant cells and neurons
Author(s) -
Hellyer Shane D.,
Albold Sabine,
Sengmany Kathy,
Singh Junaid,
Leach Katie,
Gregory Karen J.
Publication year - 2019
Publication title -
journal of neurochemistry
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.75
H-Index - 229
eISSN - 1471-4159
pISSN - 0022-3042
DOI - 10.1111/jnc.14844
Subject(s) - allosteric modulator , metabotropic receptor , allosteric regulation , metabotropic glutamate receptor , metabotropic glutamate receptor 5 , desensitization (medicine) , receptor , pharmacology , glutamate receptor , hek 293 cells , biology , chemistry , biochemistry
Allosteric modulators of metabotropic glutamate receptor 5 (mGlu 5 ) are a promising therapeutic strategy for a number of neurological disorders. Multiple mGlu 5 ‐positive allosteric modulator (PAM) chemotypes have been discovered that act as either pure PAMs or as PAM‐agonists in recombinant and native cells. While these compounds have been tested in paradigms of receptor activation, their effects on receptor regulatory processes are largely unknown. In this study, acute desensitization of mGlu 5 mediated intracellular calcium mobilization by structurally diverse mGlu 5 orthosteric and allosteric ligands was assessed in human embryonic kidney 293 cells and primary murine neuronal cultures from both striatum and cortex. We aimed to determine the intrinsic efficacy and modulatory capacity of diverse mGlu 5 PAMs [(R)‐5‐((3‐fluorophenyl)ethynyl)‐N‐(3‐hydroxy‐3‐methylbutan‐2‐yl)picolinamide (VU0424465), N ‐cyclobutyl‐6‐((3‐fluorophenyl)ethynyl)picolinamide (VU0360172), 1‐(4‐(2,4‐difluorophenyl)piperazin‐1‐yl)‐2‐((4‐fluorobenzyl)oxy)ethanone (DPFE), ((4‐fluorophenyl) (2‐(phenoxymethyl)‐6,7‐dihydrooxazolo[5,4‐c]pyridin‐5(4H)‐yl)methanone) (VU0409551), 3‐Cyano‐N‐(1,3‐diphenyl‐1H‐pyrazol‐5‐yl)benzamide (CDPPB)] on receptor desensitization and whether cellular context influences receptor regulatory processes. Only VU0424465 and VU0409551 induced desensitization alone in human embryonic kidney 293‐mGlu 5 cells, while all PAMs enhanced (S)‐3,5‐dihydroxyphenylglycine (DHPG)‐induced desensitization. All mGlu 5 PAMs induced receptor desensitization alone and enhanced DHPG‐induced desensitization in striatal neurons. VU0424465 and VU0360172 were the only PAMs that induced desensitization alone in cortical neurons. With the exception of (CDPPB), PAMs enhanced DHPG‐induced desensitization in cortical neurons. Moreover, differential apparent affinities, efficacies, and cooperativities with DHPG were observed for VU0360172, VU0409551, and VU0424465 when comparing receptor activation and desensitization in a cell type‐dependent manner. These data indicate that biased mGlu 5 allosteric modulator pharmacology extends to receptor regulatory processes in a tissue dependent manner, adding yet another layer of complexity to rational mGlu 5 drug discovery.